Bryce Joanne 4
4 · Disc Medicine, Inc. · Filed Dec 14, 2023
Insider Transaction Report
Form 4
Bryce Joanne
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-12-12$2.65/sh+2,500$6,625→ 5,000 total - Sale
Common Stock
2023-12-12$65.22/sh−2,500$163,062→ 2,500 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-12−2,500→ 2,253 totalExercise: $2.65Exp: 2030-10-22→ Common Stock (2,500 underlying)
Footnotes (3)
- [F1]The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.05 to $65.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The shares underlying this option vest in 48 equal monthly installments following January 1, 2020, subject to the Reporting Person's continued service on each such vesting date.